CDKN2A and oropharynx cancer: The host genes TP53 and cyclin-dependent kinase inhibitor 2A (CDKN2A)—most frequently affected in HPV-independent head and neck cancers, including oropharyngeal cancer—are largely unaffected in HPV-AOC (71).